The use of mirDIP software has also allowed us to identify differentially expressed miRNAs that were down-regulated in bladder cancer and therefore responsible for the increase of gene expression of MMP-9 and NGAL in cancer patients. The gene discussed is MMP9; the disease is urinary bladder carcinoma.